» Articles » PMID: 28107648

PARP-1 Controls the Adipogenic Transcriptional Program by PARylating C/EBPβ and Modulating Its Transcriptional Activity

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2017 Jan 21
PMID 28107648
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Poly(ADP-ribosyl)ation (PARylation) is a post-translational modification of proteins mediated by PARP family members, such as PARP-1. Although PARylation has been studied extensively, few examples of definitive biological roles for site-specific PARylation have been reported. Here we show that C/EBPβ, a key pro-adipogenic transcription factor, is PARylated by PARP-1 on three amino acids in a conserved regulatory domain. PARylation at these sites inhibits C/EBPβ's DNA binding and transcriptional activities and attenuates adipogenesis in various genetic and cell-based models. Interestingly, PARP-1 catalytic activity drops precipitously during the first 48 hr of differentiation, corresponding to a release of C/EBPβ from PARylation-mediated inhibition. This promotes the binding of C/EBPβ at enhancers controlling the expression of adipogenic target genes and continued differentiation. Depletion or chemical inhibition of PARP-1, or mutation of the PARylation sites on C/EBPβ, enhances these early adipogenic events. Collectively, our results provide a clear example of how site-specific PARylation drives biological outcomes.

Citing Articles

Reduction of Chemokine CXCL9 Expression by Omega-3 Fatty Acids via ADP-Ribosylhydrolase ARH3 in MIN6 Insulin-Producing Cells.

You Y, Sarkar S, Deiter C, Elliott E, Nicora C, Mirmira R Proteomics. 2024; 25(3):e202400053.

PMID: 39648458 PMC: 11794668. DOI: 10.1002/pmic.202400053.


Olaparib promotes FABP4 expression and reduces antitumor effect in ovarian cancer cells with a mutation.

Huang W, Meng H, Xu Y, Huang L, Lou G Oncol Lett. 2024; 29(2):67.

PMID: 39619421 PMC: 11605280. DOI: 10.3892/ol.2024.14813.


EZH2 directly methylates PARP1 and regulates its activity in cancer.

Meng Q, Shen J, Ren Y, Liu Q, Wang R, Li Q Sci Adv. 2024; 10(48):eadl2804.

PMID: 39602541 PMC: 11601213. DOI: 10.1126/sciadv.adl2804.


Transcriptional regulation mechanism of PARP1 and its application in disease treatment.

Lu Y, Fu W, Xing W, Wu H, Zhang C, Xu D Epigenetics Chromatin. 2024; 17(1):26.

PMID: 39118189 PMC: 11308664. DOI: 10.1186/s13072-024-00550-w.


Development and Characterization of Recombinant ADP-Ribose Binding Reagents that Allow Simultaneous Detection of Mono and Poly ADP-Ribose.

Chiu S, Camacho C, Kraus W bioRxiv. 2024; .

PMID: 38798442 PMC: 11118544. DOI: 10.1101/2024.05.16.594588.


References
1.
Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C . PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011; 13(4):461-468. PMC: 3086520. DOI: 10.1016/j.cmet.2011.03.004. View

2.
Erener S, Mirsaidi A, Hesse M, Tiaden A, Ellingsgaard H, Kostadinova R . ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation. FASEB J. 2012; 26(6):2631-8. DOI: 10.1096/fj.11-200212. View

3.
Luo X, Kraus W . A one and a two … expanding roles for poly(ADP-ribose) polymerases in metabolism. Cell Metab. 2011; 13(4):353-355. PMC: 3104020. DOI: 10.1016/j.cmet.2011.03.011. View

4.
Gao F, Kwon S, Zhao Y, Jin Y . PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. J Biol Chem. 2009; 284(33):22263-22273. PMC: 2755950. DOI: 10.1074/jbc.M109.033118. View

5.
Luo X, Kraus W . On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 2012; 26(5):417-32. PMC: 3305980. DOI: 10.1101/gad.183509.111. View